Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Year in Review 2024 - NSCLC Perioperative Therapy

Oncology 2024 Year in Review

B. Halmos

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

Total Health

D. Carbone

The Non-Invasive Diagnosis of Lung Cancer

Memorial Sloan Kettering Cancer Center

G. Rocco

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Nodules and Lung Cancer Screening

Fox Chase Cancer Center

R. Kumar

Role of Surgery in Locally Advanced NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

ELCC 2025 Summary: Monday Morning Practice - MARIPOSA Highlights & F…

Insights from ELCC 2025

B. Halmos

Year in Review 2024 - Small Cell Lung Cancer

Nebraska Oncology Society

J. Murray

ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-…

ecancer

L. Paz-Ares

Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomi…

Fox Chase Cancer Center

J. Reuss

EGFRm Lung Cancer: Overview & Treatment Sequence

GRACE

J. Rotow

Thoracic Malignancies From an Interventional Pulmonologist's Perspec…

Fox Chase Cancer Center

C. Manley

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

Year in Review 2024 - Key Trials and Progress in SCLC Treatment

Oncology 2024 Year in Review

N. Seetharamu

Imaging of Precision Therapy in Lung Cancer

International Cancer Imaging Society (ICIS)

M. Nishino

1L IO Advances in ES-SCLC Treatment

Fox Chase Cancer Center

A. Chiang

FDA Approval of Zenocutuzumab for Advanced NRG1 Fusion-Positive NSCL…

Memorial Sloan Kettering Cancer Center

A. Schram